Depixus® is developing its MAGNA™ platform to unlock dramatic new insights into the largely unmined richness of the “dynamic genome” by detecting changes beyond the four-base sequences of DNA and RNA, paving the way to revolutionise molecular diagnostics and drug development.
Dr Jimmy Ouellet, Chief Scientist will introduce the MAGNA™ platform, and through examples, illustrate its unique capacity to transform genetic analysis, enabling new insight into the epigenome through the bias-free detection of multiple features at the single molecule level. This highly innovative technology has been recognised through the receipt of numerous grants and awards, is based on the pioneering biophysics work of the Croquette lab at France’s prestigious Ecole Normale Supérieure.
In this webinar you’ll learn:
- What is meant by the ‘dynamic genome’
- MAGNA’s potential to transform life science research
- Depixus® target applications